You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Corrections Data Set Error in: Pharmacogenetic Association of the NPPA T2238C Genetic Variant With Cardiovascular Disease Outcomes in Patients With Hypertension
Original Contributions Genetic Modifiers of Liver Disease in Cystic Fibrosis
Jaclyn R. Bartlett; Kenneth J. Friedman; Simon C. Ling; Rhonda G. Pace; Scott C. Bell; Billy Bourke; Giuseppe Castaldo; Carlo Castellani; Marco Cipolli; Carla Colombo; John L. Colombo; Dominique Debray; Adriana Fernandez; Florence Lacaille; Milan Macek Jr; Marion Rowland; Francesco Salvatore; Christopher J. Taylor; Claire Wainwright; Michael Wilschanski; Dana Zemková; William B. Hannah; M. James Phillips; Mary Corey; Julian Zielenski; Ruslan Dorfman; Yunfei Wang; Fei Zou; Lawrence M. Silverman; Mitchell L. Drumm; Fred A. Wright; Ethan M. Lange; Peter R. Durie; Michael R. Knowles; for the Gene Modifier Study Group
JAMA 2009; 302: 1076-1083.
[Abstract][Full text][PDF][ eSupplement ]
Original Contributions Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
Alan R. Shuldiner; Jeffrey R. O’Connell; Kevin P. Bliden; Amish Gandhi; Kathleen Ryan; Richard B. Horenstein; Coleen M. Damcott; Ruth Pakyz; Udaya S. Tantry; Quince Gibson; Toni I. Pollin; Wendy Post; Afshin Parsa; Braxton D. Mitchell; Nauder Faraday; William Herzog; Paul A. Gurbel
JAMA 2009; 302: 849-857.
[Abstract][Full text][PDF][ eSupplement ]
Editorials Tailoring Antiplatelet Therapy Based on Pharmacogenomics: How Well Do the Data Fit?
